Molecular mechanisms for CMT1A duplication and HNPP deletion

Annals of the New York Academy of Sciences

Volumn 883, Issue , 1999, Pages 22-35

  Boerkohl, C F ^a   Inoue, K ^a   Reiter, L T ^a   Warner, L E ^a   Lupski, J R ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIA;

CROSSING OVER; FEMALE; GENE DELETION; GENE DUPLICATION; GENETIC RECOMBINATION; GENETICS; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; MALE; REVIEW;

CHARCOT-MARIE-TOOTH DISEASE; CROSSING OVER, GENETIC; FEMALE; GENE DELETION; GENE DUPLICATION; HEREDITARY MOTOR AND SENSORY NEUROPATHIES; HUMANS; MALE; RECOMBINATION, GENETIC;

EID: 0033554364     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb08563.x     Document Type: Article

References (118)

1. LUPSKI, J. R. et al. 1991. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 66: 219-232.
2. RAEYMAEKERS, P. et al. 1991. Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1A (CMT1A). Neuromusc. Disord. 1: 93-97.
3. WISE, C. A. et al. 1993. Molecular analyses of unrelated Charcot-Marie-Tooth (CMT) disease patients suggest a high frequency of the CMT1A duplication. Am. J. Hum. Genet. 53: 853-863.
4. NELIS, E., C. VAN BROECKHOVEN, et al. 1996. Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European collaborative study. Eur. J. Hum. Genet. 4: 25-33.
5. HOOGENDUK, J.E. et al. 1992. De novo mutation in hereditary motor and sensory neuropathy type 1. Lancet 339: 1081-1082.
6. LUPSKI, J.R., L. PENTAO, L.L. WILLIAMS & P.I. PATEL. 1993. Stable inheritance of the CMT1A DNA duplication in two patients with CMT1 and NF1. Am. J. Med. Genet. 45: 92-96.
7. KAKU, D.A., G.J. PARRY, R. MALAMUT, J.R. LUPSKI & C.A. GARCIA. 1993. Nerve conduction studies in Charcot-Marie-Tooth polyneuropathy associated with a segmental duplication of chromosome 17. Neurol. 43: 1806-1808.
8. LUPSKI, J.R. 1996. Editorial: DNA diagnostics for Charcot-Marie-Tooth disease and related inherited neuropathies. Clin. Chem. 42: 995-998.
9. KILLIAN, J.M. et al. 1996. Longitudinal studies of the duplication form of Charcol-Marie-Tooth polyneuropathy. Muscle & Nerve 19: 74-78.
10. GARCIA, C.A. et al. 1995. Clinical variability in two pairs of identical twins with the Charcot-Marie-Tooth disease type 1A duplication. Neurol. 45: 2090-2093.
11. SILANDER, K. et al. 1996. A de novo duplication in 17p11.2 and a novel mutation in the Po gene in two Dejerine-Sottas syndrome patients. Hum. Mut. 8: 304-310.
12. THOMAS, P.K. et al. 1997. The phenotypic manifestations of chromosome 17p11.2 duplication. Brain 120: 465-478.
13. AUER-GRUMBACH, M., S. STRASSER-FUCHS, K. WAGNER, E. KǑRNER & F. FAZEKAS. 1998. Roussy-Lévy syndrome is a phenotypic variant of Charcot-Marie-Tooth syndrome IA associated with a duplication on chromosome 17p11.2. J. Neurol. Sci. 154: 72-75.
14. UNCINI, A. et al. 1994. Hereditary motor and sensory neuropathy with calf hypertrophy is associated with 17p11.2 duplication. Ann. Neurol. 35: 552-558.
15. KRAMPITZ, D.E., G.I. WOLFE, J.L. FLECKENSTEIN & R.J. BAROHN. 1998. Charcot-Marie-Tooth disease type 1A presenting as calf hypertrophy and muscle cramps. Neurol. 51: 1508-1509.
16. HARDING, A.E. & P.K. THOMAS. 1980. Distal and scapuloperoneal distributions of muscle involvement occurring within a family with type I hereditary motor and sensory neuropathy. J. Neurol. 224: 17-23.
17. RONEN, G.M., N. LOWRY, J.H. WEDGE, H.B. SARNAT & A. HILL. 1986. Hereditary motor sensory neuropathy type I presenting as scapuloperoneal atrophy (Davidenkow syndrome) electrophysiological and pathological studies. Can. J. Neurol. Sci. 13: 264-266.
18. GARCIA, C.A. 1998. Clinical variability of Charcot-Marie-Tooth disorders. Submitted for publication.
19. PENTAO, L., C.A. WISE, A.C. CHINAULT, P.I. PATEL & J.R. LUPSKI. 1992. Charcot-Marie-Tooth type 1A duplication appears to arise from recombination at repeat sequences flanking the 1.5-Mb monomer unit. Nature Genet. 2: 292-300.
20. CHANCE, P.F. et al. 1993. DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 72: 143-151.
21. CHANCE, P.F. et al. 1994. Two autosomal dominant neuropathies result from reciprocal DNA duplication/deletion of a region on chromosome 17. Hum. Mol. Genet. 3: 223-228.
22. ROA, B.B., U. ANANTH, C.A. GARCIA & J.R. LUPSKI. 1995. Molecular diagnosis of CMT1A and HNPP. Lab. Med. Int. 12: 22-24.
23. LORENZETTI, D. et al. 1995.A 1.5-Mb deletion in 17p11.2-p12 is frequently observed in Italian families with hereditary neuropathy with liability to pressure palsies. Am. J. Hum. Genet. 56: 91-98.
24. REITER, L.T. et al. 1996. A recombination hotspot responsible for two inherited peripheral neuropathies is located near a mariner transposon-like element. Nature Genet. 12: 288-297.
25. KIYOSAWA, H., M.W. LENSCH & P.F. CHANCE. 1995. Analysis of the CMT1A-REP repeat: mapping crossover breakpoints in CMT1A and HNPP. Hum. Mol. Genet. 4: 2327-2334.
26. TIMMERMAN, V. et al. 1997. Detection of the CMT1A/HNPP recombination hotspot in unrelated patients of European descent. J. Med. Genet. 34: 43-49.
27. LOPES, J. et al. 1996. Recombination hot spot in a 3.2-kb region of the Charcot-Marie-Tooth type 1A repeat sequences: New tools for molecular diagnosis of hereditary neuropathy with liability to pressure palsies and of Charcot-Marie-Tooth type 1A. Am. J. Hum. Genet. 58: 1223-1230.
28. YAMAMOTO, M. et al. 1997. Locations of crossover breakpoints within the CMT1A-REP repeat in Japanese patients with CMT1A and HNPP. Hum. Genet. 99: 151-154.
29. REITER, L.T. et al. 1998. Human meiotic recombination products revealed by sequencing a hotspot for homologous strand exchange in multiple HNPP deletion patients. Am. J. Hum. Genet. 62: 1023-1033.
30. LOPES, J. et al. 1998. Fine mapping of de navo CMT1A and HNPP rearrangements within CMT1A-REPs evidences two distinct sex-dependent mechanisms and candidate sequences involved in recombination. Hum. Mol. Genet. 7: 141-148.
31. LOPES, J. et al. 1997. Analysis of the crossover breakpoints in 24 CMT1A and 3 HNPP de novo patients. In 6th Annual Symposium of the European Charcot-Marie-Tooth Consortium. Eds.: Antwerp, Belgium.
32. ROBERTSON, H.M. & R. MARTOS. 1997. Molecular evolution of the second ancient human mariner transposon, Hsmar2, illustrates patterns of neutral evolution in the human genome lineage. Gene 205: 219-228.
33. SHEN, P. & H.V. HUANG. 1986. Homologous recombination in Escherichia coli: dependence on substrate length and homology. Genetics 112: 441-457.
34. JINKS-ROBERTSON, S., M. MICHELITCH & S. RAMCHARAN. 1993. Substrate length requirements for efficient mitotic recombination in Saccharomyces cerevisiae. Mol. Cell. Biol. 13: 3937-3950.
35. LISKAY, R.M., A. LETSOU & J.L. STACHELEK. 1987. Homology requirement for efficient gene conversion between duplicated chromosomal sequences in mammalian cells. Genetics 115: 161-167.
36. WALDMAN, A.S. & R.M. LISKAY. 1988. Dependence of intrachromosomal recombination in mammalian cells on uninterrupted homology. Mol. Cell. Biol. 8: 5350-5357.
37. PALAU, F. et al. 1993. Origin of the de novo duplication in Charcot-Marie-Tooth disease type 1A: unequal nonsister chromatid exchange during spermatogenesis. Hum. Mol. Genet. 2: 2031-2035.
38. HERTZ, J.M., A.D. BORGLUM, C.A. BRANDT, T. FLINT & C. BISGAARD. 1994. Charcot-Marie-Tooth disease type 1A: the parental origin of a de novo 17p11.2-p12 duplication. Clin. Genet. 46: 291-294.
39. MANCARDI, G.L. et al. 1994. 17p11.2 duplication is a common finding in sporadic cases of Charcot-Marie-Tooth type 1. Eur. Neurol. 34: 135-139.
40. BLAIR, I.P., J. NASH, M.J. GORDON & G.A. NICHOLSON, 1996. Prevalence and origin of de novo duplications in Charcot-Marie-Tooth disease type 1 A: first report of a de novo duplication with a maternal origin. Am. J. Hum. Genet. 58: 472-476.
41. MARIMAN, E.C.M. et al. 1994. Evidence for genetic heterogeneity underlying hereditary neuropathy with liability to pressure palsies. Hum. Genet. 93: 151-156.
42. TIMMERMAN, V. et al. 1996. Molecular genetic analysis of the 17p11.2 region in patients with hereditary neuropathy with liability to pressure palsies (HNPP), Hum. Genet. 97: 26-34.
43. VERHALLE, D. et al. 1994. Deletion in the CMT1A locus on chromosome 17p11.2 in hereditary neuropathy with liability to pressure palsies. Ann. Neurol. 35: 704-708.
44. REISECKER, F. et al. 1994. A sporadic form of hereditary neuropathy with liability to pressure palsies: clinical, electrodiagnostic, and molecular genetic findings. Neurol. 44: 753-755.
45. LEGUERN, E. et al. 1996. A de novo case of hereditary neuropathy with liability to pressure palsies (HNPP) of maternal origin: a new mechanism for deletion in 17p11.2? Hum. Mol. Genet. 5: 103-106.
46. REITER, L.T., T. MURAKAMI, T. KOEUTH, R.A. GIBBS & J.R. LUPSKI. 1997. The human COX10 gene is disrupted during homologous recombination between the 24-kb proximal and distal CMT1A-REPs. Hum. Mol. Genet. 6: 1595-1603.
47. KIYOSAWA, H. & P.F. CHANCE. 1996. Primate origin of the CMT1A-REP repeat and analysis of a putative transposon-associated recombinational hotspot. Hum. Mol. Genet. 5: 745-753.
48. MURAKAMT, T., L.T. REITER & J.R. LUPSKI. 1997. Genomic structure and expression of the human heme A:farnesyltransferase (COX10) gene. Genomics 42: 161-184.
49. KENNERSON, M.L. et al. 1997. The Charcot-Marie-Tooth binary repeat contains a gene transcribed from the opposite strand of a partially duplicated region of the COX10 gene. Genomics 46: 61-69.
50. VALENTIJN, L.J. et al. 1992. The peripheral myelin gene PMP22/GAS-3 is duplicated in Charcot-Marie-Tooth disease type 1A. Nature Genet. 1: 166-170.
51. MATSUNAMI, N. et al. 1992. Peripheral myelin protein-22 gene maps in the duplication in chromosome 17p11.2 associated with Charcot-Marie-Tooth IA. Nature Genet. 1: 176-179.
52. PATEL, P.I. et al. 1992. The gene for the peripheral myelin protein PMP-22 is a candidate for Charcot-Marie-Tooth disease type IA. Nature Genet. 1: 159-165.
53. TIMMERMAN, V. et al. 1992. The peripheral myelin protein gene PMP22 is contained within the Charcot-Marie-Tooth disease type 1A duplication. Nature Genet. 1: 171-175.
54. Murakami, T., Z.S. Sun, C.C. Lee & J.R. Lupski. 1997. Isolation of novel genes from the CMT1A duplication/HNPP deletion critical region in 17p11.2-p12. Genomics 39: 99-103.
55. IONASESCU, V.V., R. IONASESCU, C. SEAREY & D.F. BARKER. 1993. Charcot-Marie-Tooth neuropathy IA with both duplication and nonduplication. Hum. Mol. Genet. 2: 405-410.
56. VALENTIJN, L.J. et al. 1993. Alternatively sized duplication in Charcot-Marie-Tooth disease type IA. Hum. Mol. Genet. 2: 2143-2146.
57. LUPSKI, J.R. et al. 1992. Gene dosage is a mechanism for Charcot-Marie-Tooth disease type 1A. Nature Genet. 1: 29-33.
58. ROA, B.B. et al. 1996. Duplication of the PMP22 gene in 17p partial trisomy patients with Charcot-Marie-Tooth type 1A neuropathy. Hum. Genet. 97: 642-649.
59. SUTER, U. et al. 1992. Trembler mouse carries a point mutation in a myelin gene. Nature 356: 241-244.
60. SUTER, U. et al. 1992. A leucine-to-proline mutation in the putative first transmembrane domain of the 22-kDa peripheral myelin protein in the Trembler-J mouse. Proc. Natl. Acad. Sci. USA 89: 4382-4386.
61. ROA, B. et al. 1993. Evidence for a recessive PMP22 point mutation in Charcot-Marie-Tooth disease type 1A. Nature Genet. 5: 189-194.
62. VALENTIJN, L.J. et al. 1992. Identical point mutations of PMP22 in Trembler-J mouse and Charcot-Marie-Tooth disease type 1A. Nature Genet. 2: 288-291.
63. NICHOLSON, G.A. et al. 1994. A frame shift mutation in the PMP22 gene in hereditary neuropathy with liability to pressure palsies. Nature Genet. 6: 263-266.
64. KILLIAN, J.M. & H.W. KLOEPFER. 1979. Homozygous expression of a dominant gene for Charcot-Marie-Tooth neuropathy. Ann Neurol. 5: 515-522.
65. LEGUERN, E. et al. 1997. Patients homozygous for the 17p11.2 duplication in Charcot-Marie-Tooth type 1A disease. Ann. Neurol. 41: 104-108.
66. CHANCE, P.F. et al. 1992. Trisomy 17p associated with Charcot-Marie-Tooth neuropathy type IA phenotype: evidence for gene dosage as a mechanism in CMT1A. Neurol. 42: 2295-2299.
67. UPADHYAYA, M. et al. 1993. Charcot-Marie-Tooth disease 1A (CMT1A) associated with a maternal duplication of chromosome 17p11.2->12. Hum. Genet. 91: 392-394.
68. PELLEGRINO, J.E. et al. 1996. Developmental profile in a patient with monosomy 10q and Dup(17p) associated with a peripheral neuropathy. Am. J. Med. Genet. 61: 377-381.
69. KING, P.H., R. WALDROP, J.R. LUPSKI & L.G. SHAFFER. 1998. Charcot-Marie-Tooth phenotype produced by a duplicated PMP22 gene as part of a 17p trisomy translocation to the X chromosome. Clin. Genet. 54: 413-416.
70. YOSHIKAWA, H. et al. 1994. Elevated expression of messenger RNA for peripheral myelin protein 22 in biopsied peripheral nerves of patients with Charcot-Marie-Tooth disease type 1A. Ann. Neurol. 35: 445-450.
71. VALLAT, J.-M. et al. 1996. Ultrastructural PMP22 expression in inherited demylinating neuropathies. Ann. Neurol. 39: 813-817.
72. SEREDA, M. et al. 1996. A transgenic rat model of Charcot-Marie-Tooth disease. Neuron 16: 1049-1060.
73. HUXLEY, C. et al. 1996. Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA. Hum. Mol. Genet. 5: 563-569.
74. MAGYAR, J.P. et al. 1996. Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage. J. Neurosci. 16: 5351-5360.
75. WARNER, L.E., B.B. ROA & J.R. LUPSKI. 1996. Absence of PMP22 coding region mutations in CMT1A duplication patients: further evidence supporting gene dosage as a mechanism for Charcot-Marie-Tooth disease type 1A. Hum. Mutat. 8: 362.
76. SCHENONE, A. et al. 1997. Correlation between PMP-22 messenger RNA expression and phenotype in hereditary neuropathy with liability to pressure palsies. Ann. Neurol. 42: 866-872.
77. ADLKOFER, K. et al. 1995. Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice. Nature Genet. 11: 274-280.
78. ADLKOFER, K. et al. 1997. Heterozygous peripheral myelin protein 22-deficient mice are affected by a progressive demyelinating tomaculous neuropathy. J. Neurosci. 17; 4662-4671.
79. ELLIS, D. & S. MALCOLM. 1994. Proteolipid protein gene dosage effect in Pelizaeus-Merzbacher disease. Nature Genet. 6: 333-334.
80. CREMERS, F.P.M. et al. 1987. An interstitial duplication of the X chromosome in a male allows physical fine mapping of probes from the Xq13-q22 region. Hum. Genet. 77: 23-27.
81. HUDSON, L.D., C. PUCKETT, J. BERNDT, J. CHAN & S. GENCIC. 1989. Mutation of the proteolipid protein gene PLP in a human X chromosome-linked myelin disorder. Proc. Natl. Acad. Sci. USA 86: 8128-8131.
82. INOUE, K. et al. 1996. A duplicated PLP gene causing Pelizaeus-Merzbacher disease detected by comparative multiplex PCR. Am. J. Hum. Genet, 59: 32-39.
83. INOUE, K., et al. 1998. PLP duplication causing Pelizaeus-Merzbacher disease: molecular mechanism and phenotypic manifestations. Ann. Neurol. 45: 624-632.
84. CARANGO, P., V.L. FUNANAGE, R.E. QUIROS, C.S. DEBRUYN & H.G. MARKS. 1995. Overexpression of DM20 messenger RNA in two brothers with Pelizaeus-Merzhacher disease. Ann. Neurol. 38: 610-617.
85. READHEAD, C., A. SCHNEIDER, I. GRIFFITHS & K.-A. NAVE. 1994. Premature arrest of myelin formation in transgenic mice with increased proteolipid protein gene dosage. Neuron 12: 583-595.
86. KAGAWA, T. et al. 1994. Glial cell degeneration and hypomyelination caused by overexpression of myelin proteolipid protein gene. Neuron 13: 427-442.
87. CHEN, K.-S. et al. 1997. Homologous recombination of a flanking repeat gene cluster is a mechanism for a common contiguous gene deletion syndrome. Nature Genet. 17: 154-163.
88. HALFORD, S. et al. 1993. Low-copy number repeat sequences flank the DiGeorge/velocardiofacial syndrome loci at 22q11. Hum. Mol. Genet. 2: 191-196.
89. CHRISTIAN, S.L. et al. 1995. Molecular characterization of two proximal deletion breakpoint regions in both Prader-Willi and Angelman syndrome patients. Am. J. Hum. Genet. 57: 40-48.
90. ROBINSON, W.P. et al. 1998. The mechanisms involved in formation of deletions and duplications of 15q11-q13. J. Med. Genet. 35: 130-136.
91. PÉREZ JURADO, L.A., R. PEOPLES, P. KAPLAN, B.C.J. HAMEL & U. FRANKE. 1996. Molecular definition of the chromosome 7 deletion in Williams syndrome and parent-of-origin effects on growth. Am. J. Hum. Genet. 59: 781-792.
92. URBAN, Z. et al. 1996. 7q11.23 deletions in Williams syndrome arise as a consequence of unequal meiotic crossover. Am. J. Hum. Genet. 59: 958-962.
93. ROBINSON, W.P. et al. 1996. Delineation of 7q11.2 deletions associated with Williams-Beuren syndrome and mapping of a repetitive sequence to within and to either side of the common deletion. Genomics 34: 17-23.
94. EDELMANN, L. et al. 1998. The VCFS common deletion occurs within two tandem gene clusters on 22q11 [Abstract], Am. J. Hum. Genet. 63; A54.
95. REPETTO, G.M., L.M. WHITE, P.J. BADER, D. JOHNSON & J.H. KNOLL. 1998. Interstitial duplications of chromosome region 15q11q13: clinical and molecular characterization. Am. J. Med. Genet. 79: 82-89.
96. LIFTON, R.P. et al. 1992. Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase. Nat. Genet. 2: 66-74.
97. LIFTON, R.P. et al. 1992. A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355: 262-265.
98. LEFEBVRE, S. et al. 1995. Identification and characterization of a spinal muscular atrophy determining gene. Cell 80: 155-165.
99. ROY, N. et al. 1995. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscualr atrophy. Cell 80: 167-178.
100. MELKI, J. et al. 1994. De novo and inherited deletions of the 5q13 region in spinal muscular atrophies. Science 264: 1474-1477.
101. YEN, P.H. et al. 1990. Frequent deletions of the human X chromosome distal short arm result from recombination between low copy repetitive elements. Cell 61: 603-610.
102. BALLABIO, A., B. BARDONI, S. GUIOLI, E. BASLER & G. CAMERINO. 1990. Two families of lowcopy-number repeats are interspersed on Xp22.3: implications for the high frequency of deletions in this region. Genomics 8: 263-270.
103. NATHANS, J., T.P. PIANTANIDA, R.L. EDDY, T.B. SHOWS & D.S. HOGNESS. 1986. Molecular genetics of inherited variation in human color vision. Science 232: 203-210.
104. HIGGS, D.R., J.M. OLD, L. PRESSLEY, J.B. CLEGG & D.J. WEATHERALL. 1980. A novel alpha-globin gene arrangement in man. Nature 284: 632-635.
105. LAUER, J., C.K. SHEN & T. MANIATIS. 1980. The chromosomal arrangement of human alpha-like globin genes: sequence homology and alpha-globin gene deletions. Cell 20: 119-130.
106. VNENCAK-JONES, C.L., J.A. PHILLIPS, E.Y. CHEN & P.H. SEEBURG. 1988. Molecular basis of human growth hormone gene deletions. Proc. Natl. Acad. Sci. USA 85: 5615-5619.
107. VNENCAK-JONES, C.L. & J.A. PHILLIPS. 1990. Hot spots for growth hormone gene deletions in homologous regions outside of Alu repeats. Science 250: 1745-1748.
108. LAKICH, D., H.H. KAZAZIAN, S.E. ANTONARARKIS & J. GITSCHIER. 1993. Inversions disrupting the factor VIII gene are a common cause of severe heamophilia A. Nature Genet. 5: 236-241.
109. PELLETIER, J. et al. 1991. WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour. Nature 353: 431-434.
110. BAIRD, P.N., N. GROVES, D.A. HABER, D.E. HOUSMAN & J.K. COWELL. 1992. Identification of mutations in the WT1 gene in tumours from patients with the WAGR syndrome. Oncogene 7: 2141-2149.
111. BROWN, K.W. et al. 1992. Inactivation of the remaining allele of the WT1 gene in a Wilms' tumour from a WAGR patient. Oncogene 7: 763-768.
112. PETRIJ, F. et al. 1995. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature 376: 348-351.
113. LO NIGRO, C. et al. 1997. Point mutations and an intragenic deletion in LISI, the lissencephaly causative gene in isolated lissencephaly sequence and Miller-Dieker syndrome. Hum. Mol. Genet. 6: 157-164.
114. DOBYNS, W.B., O. REINTER, R. CARROZZO & D.H. LEDBETTER. 1993. Lissencephaly: a human brain malformation associated with deletion of the LISI gene located at chromosome 17p13. J. Am. Med. Assoc. 270: 2838-2842.
115. MALZAC, P. et al. 1998. Mutation analysis of UBE3A in Angelman syndrome patients. Am. J. Hum. Genet. 62: 1353-1360.
116. MATSUIJRA, T. et al. 1997. De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome. Nature Genet. 15: 74-77.
117. LUPSKI, J.R., J.R. ROTH & G.M. WEINSTOCK. 1996. Chromosomal duplications in bacteria, fruit flies and humans. Am. J. Hum. Genet. 58: 21-27.
118. LUPSKI, J.R. 1998. Genomic disorders: structural features of the genome can lead to DNA rearrangements and human disease traits. Trends Genet. 14: 417-422.